Role of soy protein concentrate on oxidative stress and DNA fragmentation in streptozotocin-induced diabetic rats
DOI:
https://doi.org/10.56511/JIPBS.2017.v4.i04.pp16-25Abstract
Diabetes mellitus is currently a major public health concern with many pathophysiological alterations; this study aimed to evaluate the antidiabetic and protective potential of soy protein concentrate (SPC) against diabetes mellitus induced by streptozotocin (STZ) in adult male Spargue Dawely rats. The hyperglycemic groups were made with a single (ip) dose of STZ (55mg/kg b.w.). Five groups of rats were used; normal control group, SPC (200 mg/kg/day) treated group, hyperglycemic untreated group, hyperglycemic-diamicrone® 30MR (10 mg/kg/day) treated group and hyperglycemic-SPC (200 mg/kg/day) treated group. The experiment lasted for six weeks. The results revealed significant increases in blood glucose, hepatic and renal MDA and NO contents concomitant with significant depletion of GSH content and decreases in insulin level, SOD and CAT activities in the diabetic group; moreover, significant increases in serum ASAT, ALAT, GGT, urea, creainine, total cholesterol, LDL- cholesterol and triglycerides matched with a significant reduction in HDL- cholesterol and body weight values were noticed compared to control values. Interestingly, significant improvements in all biochemical, DNA fragmentation and histological determinations were observed in the diabetic-SPC treated group compared to diabetic group, especially DNA fragmentation percent. Also, diamicrone® significantly ameliorated the severity of STZ induced changes in the above mentioned parameters with the exception of DNA fragmentation which was severely elevated than diabetic group; reflecting the necessary to find more safer alternative treatments. In conclusion: the relative hypoglycemic and highly protective effects of SPC against STZ-induced diabetes mellitus may be attributed to its antioxidant and free radical scavenging mechanisms that due to its higher contents of thiol-rich amino acids and antioxidant ones
Keywords:
diabetes mellitus, soy protein, isoflavones, streptozotocinDownloads
References
Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782 – 7.
Tierney LM: Current Medical Diagnosis and Treatment. McGraw-Hill Companies, 41st edition. New York: Lange Medical Books/ Publisher; 2002, pp 241-249.
Savu O, Ionescu-Tirgoviste C, Atanasiu, V, Gaman L, Papacocea R, Stoian I: Increase in total antioxidant capacity of plasma despite high levels of oxidative stress in uncomplicated type 2 diabetes mellitus. J Int Med Res 2012; 40(2):709-6.
Neethu P, Haseena P, Kezo Z, Sona TR, Goveas SW, Abraham A: Antioxidant properties of Coscinium fenestratum stem extracts on Streptozotocin induced type 1 diabetic rats. J Appl Pharm Sci 2014; 4(1):29-32.
Yang H, Jin X, Kei Lam CW, Yan SK: Review: oxidative stress and diabetes mellitus. Clin Chem Lab Med 2011; 49(11):1773-82.
Gomathi D, Ravikumar G, Kalaiselvi M, Devaki K, Uma C: Efficacy of Evolvulus alsinoides (L.) L. on insulin and antioxidants activity in pancreas of streptozotocin induced diabetic rats. J Diabetes Metabolic Disorders 2013; 12:39.
Sushruta K, Satyanarayana S, Srinivas N, Sekhar JR: Evaluation of the blood-glucose reducing effects of aqueous extracts of the selected umbelliferous fruits used in culinary practices. Trop J Pharm 2006; 5(2):613-7.
Rahmatullah M, Ferdausi D, Mollik AH, Jahan R, Chowdhury MH, Haque WM: A survey of medicinal plants used by Kavirajes of Chalna area, Khulna district, Bangladesh. Afr J Tradit Complement Altern Med 2010; 7(2):91-97.
Tavridou A, Unwin NC, Laker MF, White M, Alberti GK: Serum concentrations of vitamin A and E in impaired glucose tolerance. Clin Chim Acta 1997; 266(2):129-40.
Magee PN, Swann PF. Nitroso compounds. Br. Med. Bull 1969; 25:2404.
Ali H, Houghton PJ, Soumyanath A: Alpha-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. J Ethnopharmacol 2010; 107(3):449-5.
Bayramoglu G , Senturk H , Bayramoglu A , Uyanoglu M , Colak S , Ozmen A , Kolankaya D : Carvacrol partially reverses symptoms of diabetes in STZ-induced diabetic rats. Cytotechnology 2014; 66(2):251-7.
Sharma A, Baluja Z: Therapeutic Effects of Glycine Max (Soybean): A Summary. International Journal of Research in Pharmacy and Biosciences 2015; 2: 22-27.
Kim HJ , Kong MK , Kim YC : Beneficial effects of Phellodendri Cortex extract on hyperglycemia and diabetic nephropathy in streptozotocininduced diabetic rats. BMB Rep 2008; 41(10):710-5.
Ruiz ‑ Larnea MB, Leal AM, Liza M, Lacort, M, de Groot H: Antioxidant effects of estradiol and 2 ‑ hydroxyestradiol on iron induced lipid peroxidation of rat liver microsome. Steriod 1994; 59:383 ‑ 388.
Perandones CE , Illera VA , Peckham D , Stunz LL , Ashman RF : Regulation of apoptosis in vitro in mature murine spleen T cells. J Immunol 1993 ; 151(7): 3521-9.
Steel RG, Torrie GH: Principles and Procedures of Statistics: A Biometrical Approach. New York: McGraw ‑ Hill 1980; p 633.
Lu MP , Wang R , Song X , Chibbar R , Wang X , Wu L , Meng, QH : Dietary soy isoflavones increase insulin secretion and prevent the development of diabetic cataracts in streptozotocin-induced diabetic rats. Nutr Res 2008; 28(7): 464-71.
Sorenson RL, Brelje TC, Roth C: Effect of tyrosine kinase inhibitors on islets of Langerhans: evidence for tyrosine kinases in the regulation of insulin secretion. Endocrinology 1994; 134(4):1975 – 78.
Jonas JC , Plant TD , Gilon P , Detimary P , Nenquin M , Henquin JC : Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets. Br J Pharmacol 1995; 114: 872 – 80.
Liu D , Zhen W , Yang Z , Carter JD , Si H , Reynolds KA : Genistein acutely stimulates insulin secretion in pancreatic β -cells through cAMPdependent protein kinase pathway. Daibetes 2006; 55:1043 – 50.
Maritim AC, Sanders RA, Watkins JB: Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol.Toxicol 2003; 17:24 – 38.
Hassan SK, El-Sammad NM, Mousa AM, Sharafeldin K, Rizvi MR: Effect of traditional plant medicines (Cinnamomum zeylanicum and Syzygium cumini) on oxidative stress and insulin resistance in streptozotocin induced diabetic rats. The Journal of Basic & Applied Zoology 2015; 72:126 – 134.
Tsikas D: Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological Challenges 2017; 524 :13 – 30.
Gross SS, Wolin MS: Nitric oxide: pathophysiological mechanism. Annu. Rev. Physiol 1995; 57:737-69.
Sellamuthu PS, Arulselvan P, Kamalraj S, Fakurazi S, Kandasamy M: Protective nature of mangiferin on oxidative stress and antioxidant status in tissues of streptozotocin-induced diabetic rats. ISRN Pharmacol 2013; 24: 234-240.
Yang HY, Tzeng YH, Chai CY, Hsieh AT, Chen JR, Chang LS, Yang SS: Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis. Nutrition 2011; 27: 943 – 8.
Lorenzi M: The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp Diabetes Res 2007; 2007:1-10.
Almeida DAT, Braga CP, Novelli ELB, Fernandes A: Evaluation of lipid profile and oxidative stress in STZ-induced rats treated with antioxidant vitamin. Braz Arch Biol Technol 2012; 55(4):527-36.
Sinzato YK, Lima PH, Campos KE, Kiss AC, Rudge, MV, Damasceno DC: Neonatally-induced diabetes: lipid profile outcomes and oxidative stress status in adult rats. Rev Assoc Med Bras 2009; 55(4):384-8.
Basha MP, Saumya SM: Influence of fluoride on streptozotocin induced diabetic nephrotoxicity in mice: Protective role of Asian ginseng (Panax ginseng) & banaba (Lagerstroemia speciosa) on mitochondrial oxidative stress. Indian J Med Res 2013:137, 370-9.
Mukhopadhyay P, Rajesh M, Horvath B, Batkai S, Park O, Tanchian G, et al: Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death. Free.Radic. Biol. Med 2011; 50: 1368-1381.
Takasu N, Komiya I, Asawa T, Nagasawa Y, YamadaT: Streptozocinand alloxan-induced H2O2 generation and DNA fragmentation in pancreatic islets: H2O2 as mediator for DNA fragmentation. Diabetes 1991; 40(9):1141-45.
Girija K, Lakshman K, Udaya C, Sabhya SG, Divya T: Anti-diabetic and anti-cholesterolemic activity of methanol extracts of three species of Amaranthus. Asian Pac J Trop Biomed 2011; 1(2):133-8.
Singh S, Garg V, Yadav D: Antihyperglycemic and antioxidative ability of Stevia rebaudiana (Bertoni) leaves in diabetes induced mice. Int J Pharm Pharm Sci, 5(Suppl. 2) 2013; 297-302.
Al-Jamal A, Alqadi T: Effects of rosemary (Rosmarinus officinalis) on lipid profile of diabetic rats. Jordan Journal of Biological Sciences 2011; 4(4):199-204.
Wang R, Ding G, Liang W, Chen C, Yang H: Role of LOX-1 and ROS in oxidized low-density lipoprotein induced epithelial mesenchymal transition of NRK52E. Lipids Health Dis 2010; 9: 120-127.
Xiang FL, Lu X, Strutt B, Hill DJ, Feng Q: NOX2 deficiency protects against streptozotocin-induced beta-cell destruction and development of diabetes in mice. Diabetes, 2010; 59(10):2603-11.
Musabayane CT, Mahlalela N, Shode FO, Ojewole JA: Effects of Syzygium cordatum (Hochst.) [Myrtaceae] leaf extract on plasma glucose and hepatic glycogen in streptozotocin-induced diabetic rats. J Ethnopharmacol 2005; 97(3): 485-90.
Choudhary M, Aggarwal N, Choudhary N, Gupta P, Budhwar V: Effect of aqueous and alcoholic extract of Sesbania sesban (Linn.) Merr root on glycemic control in streptozotocin-induced diabetic mice. Drug Dev Ther 2014; 5(2):115-122.
Calisti L, Tognetti S. Measure of glycosylated hemoglobin. Acta Biomed 2005; 76:59 – 62.
Moulisha B, Karan TK, Kar B, Bhattacharya S, Ghosh AK, Kumar RB: Hepatoprotective activity of Terminalia arjuna leaf against paracetamolinduced liver damage in rats. Asian J Chem 2011; 23:1739-1742.
Baynes JW, Thorpe SR: Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48:1 – 9.
Lin Y, Sun Z: Current views on type 2 diabetes. Journal of Endocrinology 2010; 204:1 – 11.
Mohammed MH, Farrag, AH, Hashim AN, Werner V, Nawwar MA: Hypoglycemic and antioxidant activities of Caesalpinia ferrea Martius leaf extract in streptozotocin-induced diabetic rats. J Trop Biomed 2015; 5(6):462 – 471.
Aurell M, Bjorck S: Determinants of progressive renal disease in diabetes mellitus. Kidney Int. Suppl 1992; 36:S38 – S42.
Prabhu KS, Lobo R, Shirwaikar A: Antidiabetic properties of the alcoholic extract of Sphaeranthus indicus in streptozotocin nicotinamide diabetic rats. J. Pharm. Pharmacol 2008; 60:909 – 1016.
Wu CC, Hung CN, Shi YC, Wang CJ, Huang HP: Myrciaria cauliflora extracts attenuate diabetic nephropathy involving the Ras signaling pathway in streptozotocin/nicotinamide mice on a high fat diet. Journal of food and drug analysis 2016;24:136 – 46
Potter SM: Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 1995; 125:606S – 611S.
Bishov SJ, Henick AS: Antioxidant effect of protein hydrolysates in a freeze dried model system. J Food Sci 1972; 37:873-75.
Yee JJ, Shipe WF, Kinsella JE:Antioxidant effects of soy protein hydrolysates on copper-catalyzed methyl linoleate oxidation. J Food Sci 1980; 45:1082-83.
Desfaits, AC, Serri O, Renier G: Normalization of plasma lipid peroxides, monocyte adhesion, and tumor necrosis factor alpha production in NIDDM patients after gliclazide treatment . Diabetes Care 1998; 2:487 – 93.
Chitturi S , Le V , Kench J , Loh C , George J : Gliclazide-induced acute hepatitis with hypersensitivity features. Digestive Diseases and Sciences 2002; 47(5):1107 – 10.
Forsythe WA: Comparison of dietary casein or soy protein effects on plasma lipids and hormone concentrations in the gerbil (Meriones unguiculatus). J Nutr 1986; 116:1165 – 71.
Sirtori CR, Lovati MR, Manzoni C, Gianazza E, Bondioli A, Staels B: Reduction of serum cholesterol by soybean proteins: clinical experience and potential molecular mechanisms. Nutr Metab Cardiovasc Dis 1998; 8:334 – 340.
Tachibana N, Matsumoto I, Fukui K, Arai S, Kato H, Abe K: Intake of soy protein isolate alters hepatic gene expression in rats. J Agric Food Chem 2005; 53:4253 – 57.
Bakhit RM, Klein BP, Essex-Sorlie D, Ham JO, Erdman JW, Jr, Potter SM: Intake of 25 g soybean protein reduces plasma cholesterol in men with elevated cholesterol concentrations. J Nutr 1994; 124:213 – 22.
Wei H, Bowen R, Cai Q, Barnes S, Wang Y: Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 1995; 208:124 – 130.
Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982; 307:652 – 659.
Kontessis P, Jones SL, Dodds R: Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int 1990; 38:136 – 144.
Chen ST, Yang HY, Huang HY, Peng SJ, Chen JR: Effects of various soya protein hydrolysates on lipid profile, blood pressure and renal function in five-sixths nephrectomized rats. Br J Nutr 2006; 96:435-441.
James W, Anderson MD: Beneficial effects of soy protein consumption for renal function. Asia Pac J Clin Nutr 2008; 17 (S1): 324-32.
Sarhan NA, El-Denshary ES, Hassan NS, Abu-Salem FM, Mosaad A. Abdel-Wahhab MA: Isoflavones-Enriched soy protein prevents CCL4induced hepatotoxicity in rats. ISRN Pharmacology 2012; 12:18.
Waer HF, Helmy SA: Cytological and histochemical studies in rat liver and pancreas during progression of streptozotocin induced diabetes and possible protection of certain natural antioxidants. J Nutr Food Sci 2012; 2:9-15.
Eoh SL, Abd Latiff A, Das S: Histological changes in the kidneys of experimental diabetic rats fed with Momordica charantia (bitter gourd) extract. Romanian Journal of Morphology and Embryology 2010; 51(1):91 – 95.
Tolman KG, Fonseca V, Dalpiaz A, Tan MH: Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes care 2007; 30: 734-743.
Kohl T, Gehrke N, Schad A, Nagel M, Worns MA, Sprinzl MF, Zimmermann T, He YW, Galle PR, Schuchmann M, Schattenberg JM: Diabetic liver injury from streptozotocin is regulated through the caspase8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cells. Cell Death and Disease 2013; 4: 1-9.
Jandeleit-Dahm KA, Lassila M, Allen TJ: Advanced glycation end products in diabetes-associated atherosclerosis and renal disease: interventional studies. Ann N Y Acad Sci 2005; 1043: 759-766.
Ramesh B, Pugalendi KV: Impact of umbelliferone [7-hydroxycoumarin] on hepatic marker enzymes in streptozotocin diabetic rats. Indian J Pharmacol. 2006; 38: 209-210.
Liu HR, Tang XY, Dai DZ, Dai Y: Ethanol extracts of rehmannia complex [Di Huang] containing no cornifructus improve early diabetic nephropathy by combining suppression on the ET-ROS axis with modulate hypoglycemic effect in rats. J Ethnopharmacol. 2008; 118: 466472.
Fair DE, Ogborn MR, Weiler HA, Bankovic-Calic N, Nitschmann EP, Fitzpatrick-Wong SC, Aukema HM: Dietary soy protein attenuates renal disease Progression after 1and 3 weeks in Han:SPRD-cy weanling rats. Journal of Nutrition 2004; 22:1504-1507.
Published
How to Cite
Issue
Section
Copyright (c) 2017 Hagar H. Mourad, Mahitab I. EL-Kassaby, Enas A El-Hussieny, Reham S. Esmail, Fathia A. Mannaa, Khaled G. Abdel-Wahhab
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at